Literature DB >> 28376350

Production of Zr-89 using sputtered yttrium coin targets 89Zr using sputtered yttrium coin targets.

Stacy Lee Queern1, Tolulope Aramide Aweda2, Adriana Vidal Fernandes Massicano2, Nicholas Ashby Clanton2, Retta El Sayed2, Jayden Andrew Sader3, Alexander Zyuzin3, Suzanne Elizabeth Lapi4.   

Abstract

An increasing interest in zirconium-89 (89Zr) can be attributed to the isotope's half-life which is compatible with antibody imaging using positron emission tomography (PET). The goal of this work was to develop an efficient means of production for 89Zr that provides this isotope with high radionuclidic purity and specific activity. We investigated the irradiation of yttrium sputtered niobium coins and compared the yields and separation efficiency to solid yttrium coins. The sputtered coins were irradiated with an incident beam energy of 17.5MeV or 17.8MeV providing a degraded transmitted energy through an aluminum degrader of 12.5MeV or 12.8MeV, respectively, with various currents to determine optimal cyclotron conditions for 89Zr production. Dissolution of the solid yttrium coin took 2h with 50mL of 2M HCl and dissolution of the sputtered coin took 15-30min with 4mL of 2M HCl. During the separation of 89Zr from the solid yttrium coins, 77.9 ± 11.2% of the activity was eluted off in an average of 7.3mL of 1M oxalic acid whereas for the sputtered coins, 91 ± 6% was eluted off in an average of 1.2mL of 1M oxalic acid with 100% radionuclidic purity. The effective specific activity determined via DFO-SCN titration from the sputtered coins was 108±7mCi/μmol as compared to 20.3mCi/μmol for the solid yttrium coin production. ICP-MS analysis of the yttrium coin and the sputtered coins showed 99.99% yttrium removed with 178μg of yttrium in the final solution and 99.93-100% of yttrium removed with remaining range of 0-42μg of yttrium in the final solution, respectively. The specific activity calculated for the solid coin and 3 different sputtered coins using the concentration of Zr found via ICP-MS was 140±2mCi/μmol, 300±30mCi/μmol, 410±60mCi/μmol and 1719±5mCi/μmol, respectively. Labeling yields of the 89Zr produced via sputtered targets for 89Zr- DFO-trastuzumab were >98%. Overall, these results show the irradiation of yttrium sputtered niobium coins is a highly effective means for the production of 89Zr.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Degrader; Isotope production; Sputtered coins; Yttrium; Zirconium-88; Zirconium-89

Mesh:

Substances:

Year:  2017        PMID: 28376350     DOI: 10.1016/j.nucmedbio.2017.03.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

Review 1.  Progress of Coordination and Utilization of Zirconium-89 for Positron Emission Tomography (PET) Studies.

Authors:  Minh Thanh La; Van Hieu Tran; Hee-Kwon Kim
Journal:  Nucl Med Mol Imaging       Date:  2019-01-29

2.  Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.

Authors:  Adriana V F Massicano; Supum Lee; Bryant K Crenshaw; Tolulope A Aweda; Retta El Sayed; Ian Super; Ron Bose; Bernadette V Marquez-Nostra; Suzanne E Lapi
Journal:  Cancer Biother Radiopharm       Date:  2019-01-24       Impact factor: 3.099

3.  89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma.

Authors:  Raquel Benedetto; Adriana V F Massicano; Bryant K Crenshaw; Renato Oliveira; Rui M Reis; Elaine B Araújo; Suzanne E Lapi
Journal:  Cancer Biother Radiopharm       Date:  2019-03-13       Impact factor: 3.099

4.  A new solid target design for the production of 89Zr and radiosynthesis of high molar activity [89Zr]Zr-DBN.

Authors:  Mukesh K Pandey; Aditya Bansal; Jason R Ellinghuysen; Daniel J Vail; Heather M Berg; Timothy R DeGrado
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-02-15

Review 5.  89 Zr-ImmunoPET companion diagnostics and their impact in clinical drug development.

Authors:  Brooke N McKnight; Nerissa T Viola-Villegas
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

Review 6.  Recent Advances in Zirconium-89 Chelator Development.

Authors:  Nikunj B Bhatt; Darpan N Pandya; Thaddeus J Wadas
Journal:  Molecules       Date:  2018-03-12       Impact factor: 4.411

7.  Production and Semi-Automated Processing of 89Zr Using a Commercially Available TRASIS MiniAiO Module.

Authors:  Vijay Gaja; Jacqueline Cawthray; Clarence R Geyer; Humphrey Fonge
Journal:  Molecules       Date:  2020-06-05       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.